VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Everest Medicines Enters Agreement with Corxel Pharmaceuticals for Greater China Development and Commercialization of LNZ100
Everest Medicines Enters Agreement with Corxel Pharmaceuticals for Greater China Development and Commercialization of LNZ100
Jun 08, 2026 07:02 CST Updated 09:25
Share:
Everest Medicines
Developer of Innovative Therapies
Corxel Pharmaceuticals Hong Kong
Cardiovascular Metabolic Disease Treatment Drug Developer